Welcome

CardioInspect is part of the Tel-Aviv University Future Technology Development L.P. and is dedicated for developing technology and product-line to enable the diagnosis and monitoring of Congestive Heart Failure (CHF) patients.

CardioInspect employs the bio-impedance and electrical impedance tomography (EIT) principles in order to monitor and diagnose pulmonary edema and cardiac functionality indices in CHF patients. This is done by estimating the thoracic spatial distribution of tissue resistivity, which varies significantly as pulmonary edema evolves, as well as during the cardiac cycle.

The CardioInspect technology is generic, and can be applied for monitoring a wide range of pathologies which are characterized by a change of tissue impedance. Such pathologies may be thoracic, e.g. detecting and monitoring pulmonary edema, pneumonia, cystic fibrosis, or non-thoracic as monitoring brain ischemia or cryo-surgical procedure.


CardioInspect's brochure